These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11337922)

  • 1. [Hyperhomocysteinemia as a risk factor for cardiovascular diseases].
    Kovaćević G; Andrejević-Kovaćević S; Kostić G; Novak A
    Srp Arh Celok Lek; 2000; 128(11-12):403-8. PubMed ID: 11337922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular and molecular mechanism of cardiovascular disease resulting from hyperhomocysteinemia].
    Gao L; Tang CS
    Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):335-8. PubMed ID: 12650071
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes mellitus and hyperhomocysteinemia.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2002 Feb; 2(1):87-95. PubMed ID: 16222599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperhomocysteinemia--a risk factor in atherosclerosis].
    Marković N; Stefanović V
    Srp Arh Celok Lek; 1999; 127(9-10):326-32. PubMed ID: 10649903
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperhomocysteinemia and vascular disease.
    Kohlman-Trigoboff D
    J Vasc Nurs; 2003 Mar; 21(1):30-2. PubMed ID: 12629495
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
    Austin RC; Lentz SR; Werstuck GH
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal insufficiency is an important cardiovascular risk factor].
    Pérez Flores I; Luño J
    Nefrologia; 2002; 22(4):306-9. PubMed ID: 12369120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Homocysteine and rheumatic disease].
    Tinazzi I; Caramaschi P; Patuzzo G; Bambara LM; Biasi D
    Recenti Prog Med; 2007 Dec; 98(12):646-52. PubMed ID: 18369042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homocysteine and diabetes].
    Januła A; Marek B; Kajdaniuk D; Sierek K; Borgiel-Marek H; Kos-Kudła B; Gatnar A; Gnot R; Strzyzewski A; Zeka G; Wyrwas-Bełz U
    Wiad Lek; 2005; 58(5-6):319-23. PubMed ID: 16238125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
    Alemán G; Tovar AR; Torres N
    Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On causes: Hippocrates, Aristotle, Robert Koch, and the Dread Pirate Roberts.
    Edelman ER
    Circulation; 2001 Nov; 104(21):2509-12. PubMed ID: 11714642
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 14. Are we losing homocysteine as a cardiovascular risk factor?
    Bunout D; Hirsch S
    Nutrition; 2005 Oct; 21(10):1068-9. PubMed ID: 16157246
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
    Wilson KM; Lentz SR
    Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia and vascular disease: role and implications.
    Yeolekar ME; Bichile SK; Shete MM
    J Assoc Physicians India; 2002 May; 50 Suppl():5-8. PubMed ID: 12186156
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinemia and cardiovascular disease.
    de Meer K; Stam F; van Guldener C
    Am J Clin Nutr; 2001 May; 73(5):992-3. PubMed ID: 11333857
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperhomocysteinemia as a risk factor for cardiovascular disease].
    Mukhin NA; Moiseev SV; Fomin VV
    Klin Med (Mosk); 2001; 79(6):7-14. PubMed ID: 11521389
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.